Anixa Biosciences, Inc. (ANIX)
2.95
+0.18
(+6.50%)
USD |
NASDAQ |
Oct 02, 16:00
2.94
-0.01
(-0.34%)
After-Hours: 20:00
Anixa Biosciences Net Income (Quarterly) : -2.625M for July 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -2.625M |
| April 30, 2026 | -2.536M |
| January 31, 2026 | -2.585M |
| October 31, 2025 | -2.722M |
| July 31, 2025 | -2.28M |
| April 30, 2025 | -2.813M |
| January 31, 2025 | -3.213M |
| October 31, 2024 | -2.913M |
| July 31, 2024 | -3.315M |
| April 30, 2024 | -3.18M |
| January 31, 2024 | -3.29M |
| October 31, 2023 | -2.721M |
| July 31, 2023 | -2.548M |
| April 30, 2023 | -2.307M |
| January 31, 2023 | -2.354M |
| October 31, 2022 | -3.529M |
| July 31, 2022 | -2.775M |
| April 30, 2022 | -3.588M |
| January 31, 2022 | -3.879M |
| October 31, 2021 | -4.071M |
| July 31, 2021 | -4.388M |
| April 30, 2021 | -2.437M |
| January 31, 2021 | -2.232M |
| October 31, 2020 | -2.241M |
| July 31, 2020 | -2.577M |
| Date | Value |
|---|---|
| April 30, 2020 | -2.658M |
| January 31, 2020 | -2.617M |
| October 31, 2019 | -2.111M |
| July 31, 2019 | -2.166M |
| April 30, 2019 | -2.575M |
| January 31, 2019 | -4.967M |
| October 31, 2018 | -5.392M |
| July 31, 2018 | -5.594M |
| April 30, 2018 | -1.392M |
| January 31, 2018 | -1.866M |
| October 31, 2017 | -1.786M |
| July 31, 2017 | -1.794M |
| April 30, 2017 | 0.1605M |
| January 31, 2017 | -1.589M |
| October 31, 2016 | -1.048M |
| July 31, 2016 | -1.104M |
| April 30, 2016 | -1.272M |
| January 31, 2016 | -1.593M |
| October 31, 2015 | -1.292M |
| July 31, 2015 | -1.602M |
| April 30, 2015 | -2.237M |
| January 31, 2015 | 3.752M |
| October 31, 2014 | -3.153M |
| July 31, 2014 | 0.411M |
| April 30, 2014 | -3.249M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Vicapsys Life Sciences, Inc. | -0.1046M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.606M |
| EPS Diluted (Quarterly) | -0.0762 |
| Enterprise Value | 87.06M |
| Earnings Yield | -10.51% |
| Normalized Earnings Yield | -10.51 |